07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

endocannabinoids. The molecular mechanisms underlying these selective actions are currently<br />

under investigation.<br />

Disclosures: A. Muntoni, None; G. Pillolla, None; A. Luchicchi, None; M. Melis, None; M.<br />

Pistis, None.<br />

Poster<br />

258. Molecular and Neurochemical Basis of Nicotine Addiction<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 258.2/AA5<br />

Topic: C.16.p. Neuroplasticity and addiction<br />

Support: FLADOH 05NIR-594<br />

<strong>Title</strong>: Differential effects of cannabinoid (CB) 1 receptor antagonist or bupropion in the mossy<br />

fibre reorganization following behavioral sensitization to nicotine in a rat model of noveltyseeking<br />

Authors: *A. BHATTI, C. ISGOR;<br />

Florida Atlantic Univ., BOCA RATON, FL<br />

<strong>Abstract</strong>: We have previously shown that a novelty-seeking phenotype in the outbred rat has<br />

predictive value in the expression of behavioral sensitization to nicotine. Locomotor reactivity to<br />

a novel environment is used to rank high (HR, locomotor scores ranking in the highest 1/3 rd of<br />

the population) versus low (LR, locomotor scores ranking at the lowest 1/3 rd of the population)<br />

responsiveness. HR rats are shown to express locomotor sensitization to a low dose nicotine<br />

challenge following a high dose of nicotine training and an associated increase in the mossy fibre<br />

terminal field (MF) size. Moreover, we previously showed that a cannabinoid (CB) 1 receptor<br />

antagonist administered during nicotine abstinence reverses the locomotor sensitization to<br />

nicotine challenge in the HR rats. In the present work we investigate effects of CB1 receptor<br />

antagonist and an FDA approved nicotine cessation agent, bupropion, on the mossy fibre<br />

plasticity following nicotine sensitization in the LRHR phenotype. LRHR rats underwent<br />

intermittent nicotine training with 4 injections at a medium dose (0.35 mg/kg s.c.) administered<br />

at 3-d intervals during the peripubertal-juvenile period (postnatal days 28-40). Following<br />

nicotine training, CB1 receptor antagonist AM251 (5 mg/kg; i.p.), bupropion (40 mg/kg; s.c.) or<br />

saline (1 ml/kg; s.c.) were administered on 1 st , 3rd and 5 th day of the 1 wk of abstinence.<br />

Expression of behavioral sensitization to nicotine is assessed in response to a low dose (0.1<br />

mg/kg s.c.) nicotine challenge. Five days after challenge, rats were sacrificed; hippocampi were<br />

sectioned and stained with Timm‟s silver sulfide method. MF size was estimated using

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!